Cargando…

Expression of the breast cancer resistance protein and 5-fluorouracil resistance in clinical breast cancer tissue specimens

The breast cancer resistance protein (BCRP) is a recently characterized xenobiotic half-transporter protein that acts as an energy-dependent efflux pump and may be associated with the multidrug-resistant phenotype. The aim of this study was to determine the association between BCRP expression and 5-...

Descripción completa

Detalles Bibliográficos
Autores principales:	WANG, MIN, WANG, XIANMING, YUAN, JIANHUI, GUO, LIANGFENG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915690/ https://www.ncbi.nlm.nih.gov/pubmed/24649260 http://dx.doi.org/10.3892/mco.2013.143

Ejemplares similares

Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2(+) Breast Cancer Cells to 5-Fluorouracil
por: Yi, Jianing, et al.
Publicado: (2020)

miRNA-411 acts as a potential tumor suppressor miRNA via the downregulation of specificity protein 1 in breast cancer
por: Guo, Liangfeng, et al.
Publicado: (2016)

ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells
por: Wang, Xuedong, et al.
Publicado: (2017)

Continuous 5-fluorouracil in the treatment of breast cancer.
por: Cameron, D. A., et al.
Publicado: (1994)

Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer
por: Watanabe, Takayuki, et al.
Publicado: (2021)

5-fluorouracil-induced leukoencephalopathy in patients with breast cancer.
por: Choi, S. M., et al.
Publicado: (2001)

CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal Cancer
por: Zhang, Guolin, et al.
Publicado: (2020)

Reduced Autophagy in 5-Fluorouracil Resistant Colon Cancer Cells
por: Yao, Cheng Wen, et al.
Publicado: (2017)

Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase
por: Nakamura, Ayako, et al.
Publicado: (2013)

53BP1 Sensitizes Breast Cancer Cells to 5-Fluorouracil
por: Li, Xiaoyan, et al.
Publicado: (2013)

Low expression of SPARC in gastric cancer-associated fibroblasts leads to stemness transformation and 5-fluorouracil resistance in gastric cancer
por: Ma, Yongchen, et al.
Publicado: (2019)

Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells
por: Chauvin, Anaïs, et al.
Publicado: (2022)

High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer
por: Lin, Yang, et al.
Publicado: (2015)

Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer.
por: Gabra, H., et al.
Publicado: (1996)

Cadmium influences the 5-fluorouracil cytotoxic effects on breast cancer cells
por: Asara, Y., et al.
Publicado: (2012)

LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance
por: Ma, Yu-Nan, et al.
Publicado: (2021)

HIF and COX-2 expression in triple negative breast cancer cells with hypoxia and 5-fluorouracil
por: Mori, Noriko, et al.
Publicado: (2020)

Anti-cancer effects of fenbendazole on 5-fluorouracil-resistant colorectal cancer cells
por: Park, Deokbae, et al.
Publicado: (2022)

Exosomal IDH1 increases the resistance of colorectal cancer cells to 5-Fluorouracil
por: Yang, Hao, et al.
Publicado: (2021)

Comparison of CVF (Cyclophosphamide+Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide+Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer
por: Gwak, Geumhee, et al.
Publicado: (2011)

FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10
por: Xie, Tao, et al.
Publicado: (2016)

Integrated Chromatin Accessibility and Transcriptome Landscapes of 5-Fluorouracil-Resistant Colon Cancer Cells
por: Zhang, Bishu, et al.
Publicado: (2022)

Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines
por: Berruti, A, et al.
Publicado: (2005)

Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer.
por: O'Byrne, K. J., et al.
Publicado: (1998)

Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2018)

Smart Injectable Chitosan Hydrogels Loaded with 5-Fluorouracil for the Treatment of Breast Cancer
por: Abdellatif, Ahmed A. H., et al.
Publicado: (2022)

USP11 induce resistance to 5-Fluorouracil in Colorectal Cancer through activating autophagy by stabilizing VCP
por: Sun, Hongze, et al.
Publicado: (2021)

Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil()
por: Liu, Tong, et al.
Publicado: (2019)

PLOD2 increases resistance of gastric cancer cells to 5-fluorouracil by upregulating BCRP and inhibiting apoptosis
por: Wang, Xiaohui, et al.
Publicado: (2020)

A let-7b binding site SNP in the 3′-UTR of the Bcl-xL gene enhances resistance to 5-fluorouracil and doxorubicin in breast cancer cells
por: WANG, TING, et al.
Publicado: (2015)

5-Fluorouracil: Mechanisms of Resistance and Reversal Strategies
por: Zhang, Ning, et al.
Publicado: (2008)

Insulin reverses choriocarcinoma 5- fluorouracil resistance
por: Shan, Ying, et al.
Publicado: (2021)

New Transcriptomic Biomarkers of 5-Fluorouracil Resistance
por: Fekete, János Tibor, et al.
Publicado: (2023)

CD147 Mediates 5-Fluorouracil Resistance in Colorectal Cancer by Reprogramming Glycolipid Metabolism
por: Dong, Shuohui, et al.
Publicado: (2022)

ENO1 contributes to 5-fluorouracil resistance in colorectal cancer cells via EMT pathway
por: Gu, Jinrong, et al.
Publicado: (2022)

Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer
por: Ahn, Ji-Young, et al.
Publicado: (2015)

Retraction Note: LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance
por: Ma, Yu-Nan, et al.
Publicado: (2023)

Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study
por: Ficorella, C, et al.
Publicado: (2004)

GLUT 5 Is Not Over-Expressed in Breast Cancer Cells and Patient Breast Cancer Tissues
por: Gowrishankar, Gayatri, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_26svjpkop7f987f58udhfs8hmn